Literature DB >> 22648128

Should hypertensive patients take vitamin D?

Gregoire Wuerzner1, Michel Burnier, Bernard Waeber.   

Abstract

The prevalence of both hypertension and vitamin D deficiency is high. The discovery of the vitamin D receptor and its possible effects on components of the cardiovascular system influencing blood pressure, such as the renin angiotensin system, the heart, the kidney and the blood vessels, has generated the hope that vitamin D therapy could be a new target for the treatment for hypertensive patients. Cross-sectional studies have clearly shown an association between low levels of vitamin D and hypertension. This association is not as clear in longitudinal studies. Finally, evidence from randomized controlled trials specifically designed to test the hypothesis of a blood pressure lowering effect of vitamin D is weak. Therefore, there is actually not enough evidence to recommend giving vitamin D to reduce blood pressure in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648128     DOI: 10.1007/s11906-012-0271-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  35 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  Ultraviolet B and blood pressure.

Authors:  R Krause; M Bühring; W Hopfenmüller; M F Holick; A M Sharma
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

3.  Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults.

Authors:  Ryan A Harris; Jennifer Pedersen-White; De-Huang Guo; Inger S Stallmann-Jorgensen; Daniel Keeton; Ying Huang; Yashesh Shah; Haidong Zhu; Yanbin Dong
Journal:  Am J Hypertens       Date:  2011-02-10       Impact factor: 2.689

4.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

5.  A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women.

Authors:  Karen L Margolis; Lisa W Martin; Roberta M Ray; Tessa J Kerby; Matthew A Allison; J David Curb; Theodore A Kotchen; Simin Liu; Sylvia Wassertheil-Smoller; Joann E Manson
Journal:  Am J Epidemiol       Date:  2011-11-29       Impact factor: 4.897

Review 6.  Systematic review: Vitamin D and cardiometabolic outcomes.

Authors:  Anastassios G Pittas; Mei Chung; Thomas Trikalinos; Joanna Mitri; Michael Brendel; Kamal Patel; Alice H Lichtenstein; Joseph Lau; Ethan M Balk
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

7.  The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.

Authors:  Anand Vaidya; Bei Sun; John P Forman; Paul N Hopkins; Nancy J Brown; Nikheel S Kolatkar; Gordon H Williams; Jonathan S Williams
Journal:  Clin Endocrinol (Oxf)       Date:  2011-06       Impact factor: 3.478

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice.

Authors:  Juan Kong; Yan Chun Li
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03-13       Impact factor: 3.619

10.  Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults.

Authors:  R Scragg; K T Khaw; S Murphy
Journal:  Eur J Clin Nutr       Date:  1995-09       Impact factor: 4.016

View more
  4 in total

1.  Should we be recommending vitamin D supplementation for hypertension and cardiovascular disease prevention?

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-05       Impact factor: 3.738

2.  Sequence analysis of four vitamin D family genes (VDR, CYP24A1, CYP27B1 and CYP2R1) in Vogt-Koyanagi-Harada (VKH) patients: identification of a potentially pathogenic variant in CYP2R1.

Authors:  Ma'an Abdullah Al-Barry; Alia M Albalawi; Mohammed Abu Sayf; Abdulrahman Badawi; Sibtain Afzal; Muhammad Latif; Mohammed I Samman; Sulman Basit
Journal:  BMC Ophthalmol       Date:  2016-10-04       Impact factor: 2.209

Review 3.  Vitamin D deficiency and risk of cardiovascular diseases: a narrative review.

Authors:  Babikir Kheiri; Ahmed Abdalla; Mohammed Osman; Sahar Ahmed; Mustafa Hassan; Ghassan Bachuwa
Journal:  Clin Hypertens       Date:  2018-06-22

4.  Older Age Is Associated with Decreased Levels of VDR, CYP27B1, and CYP24A1 and Increased Levels of PTH in Human Parathyroid Glands.

Authors:  Yi Jiang; Liyan Liao; Jina Li; Larry Wang; Zhongjian Xie
Journal:  Int J Endocrinol       Date:  2020-04-09       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.